Clinical Research Directory
Browse clinical research sites, groups, and studies.
STUDY00015328: Sepsis Endotypes
Sponsor: Milton S. Hershey Medical Center
Summary
Determine the utility of biomarkers measured in blood and body fluid (stool, saliva, tracheal aspirate) when combined with clinical data, for predicting sepsis phenotypes that are associated with poor clinical outcomes. We hypothesize that resistin is a biomarker which provides critical prognostic information when used in conjunction with standard clinical data, in patients with sepsis and septic shock.
Official title: Diagnostic and Prognostic Biomarkers to Elucidate Sepsis Endotypes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2020-08-06
Completion Date
2026-06-30
Last Updated
2025-09-17
Healthy Volunteers
Not specified
Conditions
Locations (1)
Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States